Showing results (1561-1570 of 1,729) with videos related to

Sort By:
Pageof 173
European Journal of Cancer (Oxford, England : 1990)|March 12, 2024
Clinical evaluation of a low-coverage whole-genome test for detecting homologous recombination deficiency in ovarian cancerRomain Boidot, Michael G B Blum, Marie-Pierre Wissler, et al.
Neuro-Oncology|September 4, 2016
The angiogenic switch leads to a metabolic shift in human glioblastomaKrishna M Talasila, Gro V Røsland, Hanne R Hagland, et al.
Acta Neuropathologica Communications|April 12, 2019
Inhibition of mitochondrial respiration prevents BRAF-mutant melanoma brain metastasisTerje Sundstrøm, Lars Prestegarden, Francisco Azuaje, et al.
Neuro-Oncology|May 8, 2014
Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomasMatthias A Karajannis, Geneviève Legault, Michael J Fisher, et al.
Plant Communications|July 4, 2024
Cytokinins regulate spatially specific ethylene production to control root growth in ArabidopsisAmel Yamoune, Marketa Zdarska, Thomas Depaepe, et al.
Cell Reports Methods|April 24, 2026
High-throughput histopathology for complex in vitro modelsMarius F Harter, Elisa D'Arcangelo, Julien Aubert, et al.
Neuro-Oncology|August 26, 2025
Prognostic stratification of newly diagnosed IDH-mutant gliomas by [18F]fluoroethyltyrosine and [11C]methionine PET - a retrospective, bicentric cohort studyMaximilian J Mair, Jan-Michael Werner, Jonathan Weller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2019
Dilution of Molecular-Pathologic Gene Signatures by Medically Associated Factors Might Prevent Prediction of Resection Status After Debulking Surgery in Patients With Advanced Ovarian CancerFlorian Heitz, Stefan Kommoss, Roshan Tourani, et al.
Oncotarget|March 10, 2016
Diagnostic and clinical relevance of the autophago-lysosomal network in human gliomasLukas Jennewein, Michael W Ronellenfitsch, Patrick Antonietti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2025
GANNET53 Part II: A European Phase I/II Trial of the HSP90 Inhibitor Ganetespib in High-Grade Platinum-Resistant Ovarian Cancer-A Study of the GANNET53 ConsortiumNicole Concin, Ioana Braicu, Pierre Combe, et al.
Pageof 173